Nyxoah SA
Country not established FDA FEI 3017191859
- Devices
- 0
- Registrations
- FDA
- FDA recalls
- 0
At a glance
Market reach
- United States
- FDA FEI
Company details
- FDA FEI number
- 3017191859
- Address
- Rue Edouard Belin 12, Mont-Saint-Guibert Brabant Wallon
- Website
- www.nyxoah.com
- [email protected]
From the company website
Nyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat OSA. Nyxoah’s lead solution is the Genio® system, a patient-centered, leadless and battery-free hypoglossal neurostimulation therapy for OSA, the world’s most common sleep disordered breathing condition that is associated with increased mortality risk and cardiovascular comorbidities.